![A line drawing of a laptop and a cup of coffee](/sites/default/files/2020-12/hero-laptop.png)
This month’s Connecting Care episode is the second in a two-part series about treatment for Hepatitis C Virus (HCV) among people with opioid use disorder.
This month’s Connecting Care episode is the second in a two-part series about treatment for Hepatitis C Virus (HCV) among people with opioid use disorder.
This discussion guide is intended to elicit a comprehensive and concrete conversation about language, stigma, and discrimination as a means of strengthening care systems and ensuring that people who seek care for HIV and/or substance use disorders, including opioid use disorder, are treated with
This webinar companion guide offers attendees a resource to supplement the information covered during a webinar and extend the webinar’s benefits beyond the allotted presentation time. It contains:
This tool focuses on the role of stigma at the intersection of HIV and OUD systems, and introduces opportunities for intervention at the systems level.
COVID-19 has changed the way society operates in countless ways. During our inaugural podcast, our team of addiction specialists and HIV providers, Drs.
This Advisory offers guidance to providers and administrators in SUD treatment programs on screening clients for hepatitis A, hepatitis B, and hepatitis C infections, as well as action steps for the treatment and support of clients with a viral hepatitis infection and a SUD.
Developed as part of the Strengthening Systems of Care for People with HIV and Opioid Use Disorder project, this document contains brief descriptions of federal policy and systems changes due to coronavirus 2019 (COVID-19) that relate to the HIV and substance use systems of care, along w